Gradient variability coefficient: a novel method for assessing glycemic variability and risk of hypoglycemia
- 23 January 2022
- journal article
- research article
- Published by Springer Science and Business Media LLC in Endocrine
- Vol. 76 (1), 29-35
- https://doi.org/10.1007/s12020-021-02950-4
Abstract
Objective Despite the clinical importance of glycemic variability and hypoglycemia, thus far, there is no consensus on the optimum method for assessing glycemic variability and risk of hypoglycemia simultaneously. Research design and methods A novel metric, the gradient variability coefficient (GVC), was proposed for characterizing glycemic variability and risk of hypoglycemia. A total of 208 daily records of CGM encompassing 104 patients with T1DM and 2380 daily records from 1190 patients with T2DM were obtained in our study. Simulated CGM waveforms were used to assess the ability of GVC and other metrics to capture the amplitude and frequency of glucose fluctuations. In addition, the association between GVC and the risk of hypoglycemia was evaluated by receiver operating characteristic (ROC) curve. Results The results of simulated CGM waveforms indicated that, compared with the widely used metrics of glycemic variability including standard deviation of sensor glucose (SD), coefficient of variation (CV), and mean amplitude of glycemic excursion (MAGE), GVC could reflect both the amplitude and frequency of glucose oscillations. In addition, the area under the curve (AUC) of ROC was 0.827 in T1DM and 0.873 in T2DM, indicating good performance in predicting hypoglycemia. Conclusions The proposed GVC might be a clinically useful tool in characterizing glycemic variability and the assessment of hypoglycemia risk in patients with diabetes.Funding Information
- National Key R&D Program of China (2018YFC2001002, 2018YFC2001002, 2018YFC2001002, 2018YFC2001002, 2018YFC2001002)
This publication has 23 references indexed in Scilit:
- International Consensus on Use of Continuous Glucose MonitoringDiabetes Care, 2017
- Pharmacologic Differences of Sulfonylureas and the Risk of Adverse Cardiovascular and Hypoglycemic EventsDiabetes Care, 2017
- Association of Glycemic Variability in Type 1 Diabetes With Progression of Microvascular Outcomes in the Diabetes Control and Complications TrialDiabetes Care, 2017
- Short‐term effects of a low carbohydrate diet on glycaemic variables and cardiovascular risk markers in patients with type 1 diabetes: A randomized open‐label crossover trialDiabetes, Obesity and Metabolism, 2017
- Poststroke glycemic variability increased recurrent cardiovascular events in diabetic patientsJournal of Diabetes and its Complications, 2016
- Measures of Glycemic Variability in Type 1 Diabetes and the Effect of Real-Time Continuous Glucose MonitoringDiabetes Technology & Therapeutics, 2016
- Glucose variability, HbA1c and microvascular complicationsReviews in Endocrine and Metabolic Disorders, 2016
- Hypoglycemia and risk of vascular events and mortality: a systematic review and meta-analysisActa Diabetologica, 2015
- Evaluation of the Mean Absolute Glucose Change as a Measure of Glycemic Variability Using Continuous Glucose Monitoring DataDiabetes Technology & Therapeutics, 2013
- Glycaemic variability and complications in patients with diabetes mellitus: evidence from a systematic review of the literatureDiabetes, Obesity and Metabolism, 2010